Effectiveness of Intensive Smoking Cessation Interventions in Patients With Cancer

Bispebjerg Hospital

Status: Completed

Conditions: Tobacco Smoking; Tobacco Cessation; Cancer

Treatments: Behavioral: Intensive Smoking Cessation Intervention

Study type: Observational

Funder types: Other

Identifiers

NCT04198688

MS254

Details and patient eligibility

About

Smoking accounts for approximately 30% of total cancer deaths each year. Even though former studies show that persons with a cancer diagnosis are less likely to smoke than the general population up to 50% of people who smoke and have lung cancer do not stop smoking after their diagnosis or frequently relapse after smoking cessation. Continued smoking leads to increased all-cause mortality, increased cancer-specific mortality, and decreased quality of life. It is well-known that cancer patients are interested in smoking cessation therefore smoking cessation interventions play an important role in the management of people with cancer.

This study will evaluate the effectiveness of an intensive smoking cessation interventions on cancer patients in real life. The project provides new knowledge about smokers diagnosed with cancer.

Full description

This prospective register-based cohort study including smokers attending an intensive smoking cessation intervention (the Gold Standard Programme (GSP)) from 2006-2017 in Denmark. The GSP is a manualised, patient education programme taught by specially trained staff, including pharmacologic strategies.

Enrollment: 77,380 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Smokers registered in the National Danish Smoking Cessation Database between January 2006 until May 2017

Exclusion criteria

• Entries referring to smokers attending more than one smoking cessation intervention (the latest entry will be used)
• Smokers younger than 18 years of age
• Smokers attending interventions other than the intensive Gold Standard Programme for smoking cessation (GSP)
• Smokers where the smoking cessation unit pre-decided not to follow up on their participants
• Smokers in the non-cancer group diagnosed with benign neoplasms, tumours of unknown etymology or non-melanoma skin cancer (ICD-10 diagnoses: D30.1-9; D32-33; D35.2-4; D41.1-9; D44.3-5; C44, C46.0)

Trial design

77,380 participants in 2 patient groups

With cancer

Description:

Patients diagnosed with cancer (with at least one of the following ICD-10 diagnoses: C00-43; C46.1-99; D09)

Treatment:

Behavioral: Intensive Smoking Cessation Intervention

Without cancer

Description:

Patients without cancer (without any of the following ICD-10 diagnoses: C00-99; D09; D30.1-9; D32-33; D35.2-4; D41.1-9; D44.3-5)

Treatment:

Behavioral: Intensive Smoking Cessation Intervention